Drug Profile
Lodaxaprine
Alternative Names: CM 40907Latest Information Update: 04 Feb 1998
Price :
$50
*
At a glance
- Originator Sanofi-Synthelabo
- Class Antiepileptic drugs; Neuroprotectants; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 19 Dec 1996 New profile
- 19 Dec 1996 Discontinued-I for Epilepsy in Germany (PO)
- 19 Dec 1996 Discontinued-II for Epilepsy in France (PO)